# PMN (Promis Neurosciences Inc.) - SEC EDGAR Financial Statements

> Promis Neurosciences Inc. reported $47.16M in total assets and a net loss of $38.81M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/PMN
- Markdown: https://convexityos.com/fundamentals/PMN.md
- SEC CIK: 0001374339
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001374339&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$40.30M | Operating profit |
| Net Income | FY 2025 | -$38.81M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$4.24 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $44.11M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Research & Development | $33.38M | $10.64M | $7.88M | $16.09M | $4.63M |
| Total Operating Expenses | $40.17M | $16.83M | $14.26M | $23.38M | $8.29M |
| **Operating Income** | -$40.17M | -$16.83M | -$14.26M | -$23.38M | -$8.29M |
| **EBITDA** | -- | -- | -$14.24M | -$23.37M | -$8.25M |
| Interest Expense | -- | -- | -- | $282K | $416K |
| Income Tax Expense | -- | $0 | $0 | $0 | -- |
| **Net Income** | -$39.72M | $2.78M | -$13.21M | -$18.06M | -$9.79M |
| Basic EPS | -$22.61 | $2.68 | -$26.75 | -$60.25 | -$42.25 |
| **Diluted EPS** | -$22.61 | $2.63 | -$26.75 | -$60.25 | -$42.25 |
| Basic Shares Outstanding | 1.8M | 1.0M | 491.7K | 300.1K | 231.4K |
| Diluted Shares Outstanding | 1.8M | 1.1M | 491.7K | 300.1K | 231.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $6.71M | $9.52M | $6.97M | $9.37M | $9.80M | $8.75M | $5.46M | $4.32M |
| Total Operating Expenses | $8.62M | $12.27M | $8.64M | $10.77M | $11.75M | $10.18M | $7.46M | $6.00M |
| **Operating Income** | -$8.62M | -$12.27M | -$8.64M | -$10.77M | -$11.75M | -$10.18M | -$7.46M | -$6.00M |
| **Net Income** | -$8.16M | -$11.73M | -$8.24M | -$10.67M | -$11.58M | -$10.12M | -$7.35M | -$238K |
| Basic EPS | -$0.89 | -$1.28 | -$1.26 | -- | -$5.93 | -$7.26 | -$5.27 | -- |
| **Diluted EPS** | -$0.89 | -$1.28 | -$1.26 | -- | -$5.93 | -$7.26 | -$5.27 | -- |
| Basic Shares Outstanding | 9.1M | 9.1M | 6.5M | -- | 2.0M | 1.4M | 1.4M | -- |
| Diluted Shares Outstanding | 9.1M | 9.1M | 6.5M | -- | 2.0M | 1.4M | 1.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.12M | $13.29M | $12.60M | $5.88M | $16.94M |
| Short-Term Investments | $34K | $33K | $32K | $31K | $33K |
| **Cash & Short-Term Investments** | $6.15M | $13.32M | $12.63M | $5.91M | $16.98M |
| **Total Current Assets** | $9.18M | $18.91M | $13.62M | $6.90M | $17.71M |
| Property, Plant & Equipment, Net | -- | -- | -- | $321 | $4.7K |
| Intangible Assets | -- | -- | -- | $21K | $28K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $21K | $32K |
| **Total Assets** | $9.18M | $18.91M | $13.62M | $6.92M | $17.75M |
| Accounts Payable | $2.54M | $1.74M | $7.84M | $2.98M | $409K |
| **Total Current Liabilities** | $10.41M | $2.22M | $9.35M | $6.41M | $929K |
| Long-Term Debt | -- | -- | $0 | -- | $3.91M |
| **Total Non-Current Liabilities** | $29K | $205K | $516K | $1.86M | $11.16M |
| **Total Liabilities** | $10.44M | $2.42M | $9.87M | $8.27M | $12.09M |
| **Total Debt (incl. Leases)** | -- | -- | $0 | -- | $3.91M |
| Common Stock | -- | -- | -- | -- | $0 |
| Retained Earnings | -$130.4M | -$90.69M | -$93.47M | -$80.25M | -$62.19M |
| Accumulated Other Comp. Income | -$371K | -$371K | -$371K | -$195K | -$188K |
| **Total Stockholders' Equity** | -$1.26M | $16.49M | $3.75M | -$1.35M | $5.66M |
| Total Equity | -$1.26M | $16.49M | $3.75M | -$1.35M | $5.66M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $44.07M | $53.43M | $63.81M | $6.12M | $15.40M | $4.51M | $8.36M | $13.29M |
| Short-Term Investments | $34K | $34K | $34K | $34K | $33K | $33K | $33K | $33K |
| **Cash & Short-Term Investments** | $44.11M | $53.46M | $63.85M | $6.15M | $15.43M | $4.54M | $8.40M | $13.32M |
| **Total Current Assets** | $47.16M | $56.69M | $65.61M | $9.18M | $21.46M | $9.51M | $13.65M | $18.91M |
| **Total Non-Current Assets** | $0 | $0 | $1.80M | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $47.16M | $56.69M | $67.41M | $9.18M | $21.46M | $9.51M | $13.65M | $18.91M |
| Accounts Payable | $485K | $1.79M | $1.72M | $2.54M | $4.21M | $2.78M | $1.20M | $1.74M |
| **Total Current Liabilities** | $5.34M | $7.22M | $6.61M | $10.41M | $12.21M | $9.82M | $4.06M | $2.22M |
| **Total Non-Current Liabilities** | $56K | $77K | $79K | $29K | $60K | $68K | $119K | $205K |
| **Total Liabilities** | $5.40M | $7.29M | $6.69M | $10.44M | $12.27M | $9.89M | $4.17M | $2.42M |
| Retained Earnings | -$158.5M | -$150.4M | -$138.7M | -$130.4M | -$119.7M | -$108.2M | -$98.03M | -$90.69M |
| Accumulated Other Comp. Income | -$371K | -$371K | -$371K | -$371K | -$371K | -$371K | -$371K | -$371K |
| **Total Stockholders' Equity** | $41.76M | $49.40M | $60.72M | -$1.26M | $9.19M | -$383K | $9.47M | $16.49M |
| Total Equity | $41.76M | $49.40M | $60.72M | -$1.26M | $9.19M | -$383K | $9.47M | $16.49M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$39.72M | $2.78M | -$13.21M | -$18.06M | -$9.79M |
| Depreciation & Amortization | -- | -- | $21K | $11K | $46K |
| Stock-Based Compensation | $858K | $826K | $272K | $488K | $516K |
| Change in Payables | $806K | -$6.11M | $4.96M | $2.68M | -$32K |
| **Operating Cash Flow** | -$28.12M | -$27.18M | -$10.84M | -$17.03M | -$9.31M |
| Capital Expenditure | -- | -- | -- | -$2.0K | -$6.0K |
| **Free Cash Flow** | -- | -- | -- | -$17.04M | -$9.31M |
| **Investing Cash Flow** | -$702 | -$693 | -$1.3K | -$2.0K | $95K |
| Common Stock Issued | $708K | $190K | -- | $4.97M | $15.87M |
| **Financing Cash Flow** | $20.94M | $27.88M | $17.75M | $6.49M | $25.52M |
| **Net Change in Cash** | -$7.17M | $693K | $6.72M | -$11.07M | $16.14M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.16M | -$11.73M | -$8.24M | -$10.67M | -$11.58M | -$10.12M | -$7.35M | -$238K |
| Stock-Based Compensation | $483K | $409K | $189K | $203K | $197K | $212K | $245K | $623K |
| Change in Payables | -$1.31M | $77K | -$827K | -$1.67M | $1.43M | $1.58M | -$537K | $162K |
| **Operating Cash Flow** | -$9.38M | -$10.39M | -$12.38M | -$9.28M | -$10.06M | -$3.85M | -$4.93M | -$8.72M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $21K | $0 | $70.08M | -- | -- | -- | -- | $470K |
| **Net Change in Cash** | -$9.36M | -$10.39M | $57.70M | -$9.28M | $10.89M | -$3.85M | -$4.93M | -$8.25M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | 16.9% | -352.0% | -- | -173.0% |
| Return on Assets (ROA) | -432.6% | 14.7% | -97.0% | -260.8% | -55.2% |
| Current Ratio | 0.88x | 8.52x | 1.46x | 1.08x | 19.07x |
| Quick Ratio | 0.59x | 6.01x | 1.35x | 0.92x | 18.27x |
| Debt to Equity | -- | -- | 0.00x | -- | 0.69x |
| **Net Income Growth (YoY)** | -1529.3% | -- | -- | -- | -- |
| EPS Growth (YoY) | -943.7% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -92.9% | -85.5% | -66.9% | -- | -318.7% | -- | -9.9% | 16.9% |
| Return on Assets (ROA) | -82.3% | -74.5% | -60.3% | -432.6% | -136.5% | -88.6% | -6.8% | 14.7% |
| Current Ratio | 8.83x | 7.85x | 9.92x | 0.88x | 1.76x | 0.97x | 3.36x | 8.52x |
| Quick Ratio | 8.26x | 7.41x | 9.65x | 0.59x | 1.26x | 0.46x | 2.07x | 6.01x |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -224.8% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -176.5% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
